Oscar Health, Inc. (OSCR)

NYSE: OSCR · USD

$30.4

-0.96 (-3.1%)· Recorded snapshot

Market cap	9.4B
Revenue (ttm)	15.3B
Net income (ttm)	550.7M
EPS (ttm)	$1.91
Shares out	308.3M
P/E (trailing)	15.9x
P/E (forward)	16.7x
Volume	3,111,421
Beta	2.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.3B
Net income (ttm): 550.7M
EPS (ttm): $1.91
P/E (trailing): 15.9x
P/E (forward): 16.7x
Market cap: 9.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E15.9

P25 n/aP50 n/aP75 n/a

ROE34.3

P25 n/aP50 n/aP75 n/a

ROIC25.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OSCR indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001568651
Company name	Oscar Health, Inc.
Country	United States
Country code	US
CUSIP number	687793109
Earnings date	2026-11-05
Earnings time	bmo
Employees	2,305
Employees change	-95
Employees growth	-3.96%
Enterprise value	$5.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
In index	RUSSELL2000
Industry	Healthcare Plans
IPO date	2021-03-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US6877931096
Last 10-K release date	2026-02-13
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$9.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$30.39
Price currency	USD
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	OSCR
U.S. state	New York
Website	https://www.hioscar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	21.71x
Earnings yield	6.28%
EV/Earnings	11.21x
EV/EBIT	9.8x
EV/EBITDA	9.38x
EV/FCF	1.41x
EV/Sales	0.4x
FCF / EV yield	70.94%
FCF yield	44.84%
Forward EV/Sales	0.31x
Forward P/E	16.71x
Forward P/S	0.49x
Graham number	16.90453
Graham upside	-46.64%
Industry forward P/E	15.03x
Industry P/E	21.44x
P/(FCF - SBC) ratio	2.27x
P/(OCF - SBC) ratio	2.25x
P/B ratio	4.71x
P/E ratio	15.93x
P/FCF ratio	2.23x
P/OCF ratio	2.21x
P/S ratio	0.64x
Price / tangible book value	4.76x
Price/EBITDA ratio	14.85x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.11%
EBITDA margin	4.3%
Effective tax rate	6.59%
FCF margin	28.59%
Gross margin	20.16%
Operating margin	4.11%
Pretax margin	3.85%
Profit margin	3.6%
Profit per employee	$238,934
Profitable quarters	2
Revenue per employee	$6.6M
ROA	4.47%
ROA (5Y)	-5.75%
ROCE	24.82%
ROE	34.26%
ROE (5Y)	-37.75%
ROIC	25.1%
ROIC (5Y)	-27.7%
SBC / revenue	0.49%
Tax / revenue	0.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-47.05%
EPS growth quarters	2
EPS growth years	0
FCF growth	264.51%
FCF growth (Q)	316.29%
FCF growth (QoQ)	-20.29%
FCF growth 3Y	205.56%
FCF growth 5Y	81.17%
Net income growth (QoQ)	-46.71%
Net income growth quarters	2
Net income growth years	0
OCF growth	257.99%
OCF growth (Q)	311.02%
OCF growth (QoQ)	-20.11%
OCF growth 3Y	188.89%
OCF growth 5Y	78.61%
Revenue growth	42.82%
Revenue growth (Q)	70.4%
Revenue growth (QoQ)	5.01%
Revenue growth 3Y	45.41%
Revenue growth 5Y	69.45%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-38.6M
EBIT	$629.7M
EBITDA	$658M
EPS	$1.91
FCF per share	$14.21
Financing cash flow	$381.9M
Free cash flow	$4.4B
Free cash flow minus SBC	$4.3B
Gross profit	$3.1B
Income taxes	$38.9M
Investing cash flow	$-3.3B
Net borrowing	$371.1M
Net cash flow	$1.5B
Net income	$550.7M
Operating cash flow minus SBC	$4.3B
Operating income	$629.7M
Revenue	$15.3B
Stock-based compensation	$75.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$6.66
Debt / EBITDA	0.72
Debt / equity	0.23
Debt / FCF	0.11
Interest coverage	39.73
Net cash (debt)	$3.6B
Net cash / market cap	36.79%
Net cash growth	60.3%
Net debt / EBITDA	-5.46
Net debt / equity	-1.75
Net debt / FCF	-0.82
Piotroski F-Score	5
Property, plant and equipment	$101.5M
Shareholders' equity	$2.1B
Tangible book value	$2.1B
Tangible book value per share	$6.66
Total assets	$11.2B
Total cash	$8.6B
Total debt	$482.1M
Total liabilities	$9.2B
WACC	17.13%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.74
Current ratio	1.08
Net working capital	$-3.4B
Quick ratio	1.05
Working capital	$683.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-17.37%
Dividend yield	0%
Shareholder yield	-17.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$26.64
1D price change	-3.06%
1M price change	2.94%
1M total return	2.94%
1W price change	-9.48%
1W total return	-9.48%
1Y price change	54.91%
1Y return CAGR	54.95%
1Y total return	54.91%
20-day SMA	$32.47
200-day SMA	$23.47
3M price change	7.52%
3M total return	7.52%
3Y price change	528.25%
3Y return CAGR	84.49%
3Y total return	528.25%
50-day SMA	$31.77
50-day SMA vs 200-day SMA	50over200
52-week high	$35.01
52-week high date	2026-10-13
52-week low	$10.69
52-week low date	2026-03-30
5Y price change	79.87%
5Y return CAGR	12.46%
5Y total return	79.87%
6M price change	77.36%
6M total return	77.36%
All-time high	$37.00
All-time high date	2021-03-10
All-time low	$2.05
All-time low date	2022-12-22
Average true range (ATR)	$1.55
Average volume	4.5M
Beta (1Y)	2.31
Beta (2Y)	0.83
Beta (5Y)	2.47
Change from 52-week high	-13.2%
Change from 52-week low	184.28%
Change from all-time high	-17.65%
Change from all-time low	1,386.34%
Change from open	-3.31%
Day's gap	0.26%
Dollar volume	$94.6M
High price	$31.76
Low price	$30.21
Monthly RSI	66.06
Open price	$31.43
Position in 52-week range	11.61%
Premarket change	-0.29%
Premarket close	$31.35
Premarket price	$31.26
Premarket volume	2.6K
Previous close	$31.35
Price vs 150-day SMA	14.38%
Price vs 20-day SMA	-6.15%
Price vs 200-day SMA	29.85%
Price vs 50-day SMA	-4.09%
Relative volume	0.69
Return from IPO open	-12%
Return from IPO price	-18.77%
RSI	41.5
Sharpe ratio	0.92
Sharpe ratio (3Y)	1.13
Sharpe ratio (5Y)	0.49
Sortino ratio	1.6
Sortino ratio (3Y)	1.98
Sortino ratio (5Y)	0.88
Volume	3.1M
Weekly RSI	56.61
YTD price change	112.04%
YTD total return	112.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	263.6M
Float percentage	85.5%
Shares change (QoQ)	1.12%
Shares change (YoY)	17.37%
Shares held by insiders	3.85%
Shares held by institutions	62.38%
Shares outstanding	308.3M
Short % of float	6.24%
Short % of shares	5.34%
Short ratio	3 days

Deeper analysis on OSCR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OSCR report

Is a complete OSCR research report available?

No complete published report is available for Oscar Health, Inc. (OSCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Oscar Health, Inc. (OSCR)

Price

Financial snapshot

Fair-value bridge

Latest news · OSCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OSCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OSCR

Frequently asked questions